Literature DB >> 11032810

Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601.

B H Zhang1, K L Guan.   

Abstract

The Raf kinase family serves as a central intermediate to relay signals from Ras to ERK. The precise molecular mechanism for Raf activation is still not fully understood. Here we report that phosphorylation of Thr598 and Ser601, which lie between kinase subdomains VII and VIII, is essential for B-Raf activation by Ras. Substitution of these residues by alanine (B-RafAA) abolished Ras-induced B-Raf activation without altering the association of B-Raf with other signaling proteins. Phosphopeptide mapping and immunoblotting with phospho-specific antibodies confirmed that Thr598 and Ser601 are in vivo phosphorylation sites induced by Ras. Furthermore, replacement of these two sites by acidic residues (B-RafED) renders B-Raf constitutively active. Con sistent with these data, B-RafAA and B-RafED exhibited diminished and enhanced ability, respectively, to stimulate ERK activation and Elk-dependent transcription. Moreover, functional studies revealed that B-RafED was able to promote NIH 3T3 cell transformation and PC12 cell differentiation. Since Thr598 and Ser601 are conserved in all Raf family members from Caenorhabditis elegans to mammals, we propose that phosphorylation of these two residues may be a general mechanism for Raf activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032810      PMCID: PMC314015          DOI: 10.1093/emboj/19.20.5429

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  58 in total

Review 1.  The Raf-1 serine/threonine protein kinase.

Authors:  N S Magnuson; T Beck; H Vahidi; H Hahn; U Smola; U R Rapp
Journal:  Semin Cancer Biol       Date:  1994-08       Impact factor: 15.707

2.  Mammalian Ras interacts directly with the serine/threonine kinase Raf.

Authors:  A B Vojtek; S M Hollenberg; J A Cooper
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

3.  Partial purification of a mitogen-activated protein kinase kinase activator from bovine brain. Identification as B-Raf or a B-Raf-associated activity.

Authors:  A D Catling; C W Reuter; M E Cox; S J Parsons; M J Weber
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

4.  Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate.

Authors:  J Wu; P Dent; T Jelinek; A Wolfman; M J Weber; T W Sturgill
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

5.  Inhibition by cAMP of Ras-dependent activation of Raf.

Authors:  S J Cook; F McCormick
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

6.  Identification of the major phosphorylation sites of the Raf-1 kinase.

Authors:  D K Morrison; G Heidecker; U R Rapp; T D Copeland
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

7.  Protein kinase C-mediated serine phosphorylation directly activates Raf-1 in murine hematopoietic cells.

Authors:  M P Carroll; W S May
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

8.  Phosphorylation of c-Raf-1 by protein kinase A interferes with activation.

Authors:  K Schramm; M Niehof; G Radziwill; C Rommel; K Moelling
Journal:  Biochem Biophys Res Commun       Date:  1994-06-15       Impact factor: 3.575

9.  Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues.

Authors:  C F Zheng; K L Guan
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

10.  Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1.

Authors:  D R Alessi; Y Saito; D G Campbell; P Cohen; G Sithanandam; U Rapp; A Ashworth; C J Marshall; S Cowley
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

View more
  93 in total

Review 1.  Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants.

Authors:  Alastair Aitken
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

Review 2.  Mechanistic principles of RAF kinase signaling.

Authors:  Christian M Udell; Thanashan Rajakulendran; Frank Sicheri; Marc Therrien
Journal:  Cell Mol Life Sci       Date:  2010-09-06       Impact factor: 9.261

3.  Positive and negative regulation of Raf kinase activity and function by phosphorylation.

Authors:  H Chong; J Lee; K L Guan
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

4.  Electrostatic mechanism of V600E mutation-induced B-Raf constitutive activation in colorectal cancer: molecular implications for the selectivity difference between type-I and type-II inhibitors.

Authors:  Tie Liu; Zhaoshun Wang; Peng Guo; Na Ding
Journal:  Eur Biophys J       Date:  2018-09-14       Impact factor: 1.733

Review 5.  Tumor adaptation and resistance to RAF inhibitors.

Authors:  Piro Lito; Neal Rosen; David B Solit
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 6.  Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.

Authors:  L Ouyang; Z Shi; S Zhao; F-T Wang; T-T Zhou; B Liu; J-K Bao
Journal:  Cell Prolif       Date:  2012-10-03       Impact factor: 6.831

7.  State-dependent Ras signaling and AMPA receptor trafficking.

Authors:  Yi Qin; Yinghua Zhu; Joel P Baumgart; Ruth L Stornetta; Kenneth Seidenman; Volker Mack; Linda van Aelst; J Julius Zhu
Journal:  Genes Dev       Date:  2005-08-17       Impact factor: 11.361

8.  Differential regulation of B-raf isoforms by phosphorylation and autoinhibitory mechanisms.

Authors:  Isabelle Hmitou; Sabine Druillennec; Agathe Valluet; Carole Peyssonnaux; Alain Eychène
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

9.  Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutants.

Authors:  Martin Köhler; Michael Röring; Björn Schorch; Katharina Heilmann; Natalie Stickel; Gina J Fiala; Lisa C Schmitt; Sandra Braun; Sophia Ehrenfeld; Franziska M Uhl; Thorsten Kaltenbacher; Florian Weinberg; Sebastian Herzog; Robert Zeiser; Wolfgang W Schamel; Hassan Jumaa; Tilman Brummer
Journal:  EMBO J       Date:  2015-12-10       Impact factor: 11.598

10.  PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.

Authors:  Frank Schönleben; Wanglong Qiu; Helen E Remotti; Werner Hohenberger; Gloria H Su
Journal:  Langenbecks Arch Surg       Date:  2008-02-21       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.